Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy

Published:2022-09 Issue: Volume:74 Page:11-18
ISSN:0033-0620
Container-title:Progress in Cardiovascular Diseases
language:en
Short-container-title:Progress in Cardiovascular Diseases

Author:

Hutt Erika,Mentias Amgad,Alashi Alaa,Wadhwa Raoul,Fava Agostina,Lever Harry M.,Thamilarasan Maran,Popovic Zoran B.,Smedira Nicholas G.,Desai Milind Y.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

2. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Ommen;J Am Coll Cardiol,2020

3. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy;Maron;N Engl J Med,2003

4. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy;Elliott;Eur Heart J,2006

5. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction;Maron;Circulation,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction;Circulation Journal;2024-07-25

2. The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy: A Meta-Analysis and Systematic Review;The American Journal of Cardiology;2024-01

3. A systematic review and meta-analysis of sex differences in clinical outcomes of hypertrophic cardiomyopathy;Frontiers in Cardiovascular Medicine;2023-12-05